Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application crawled time : 17:00 save search
Job Application Tracking in a Cookie-less World
Published: 2024-03-21 (Crawled : 17:00) - veritone.com
VERI | $3.86 2.12% 2.07% 760K
|
Technology Services
|
| O: 1.01%
H: 1.5%
C: -8.25%
world application
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
iclusig fda drug takeda approval application
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA®
Published: 2024-02-19 (Crawled : 17:00) - biospace.com/
OCUL | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
| Email alert
Add to watchlist
dextenza drug health sciences application therapeutics
European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-01-26 (Crawled : 17:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -6.38%
H: 0.88%
C: 0.88%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.09%
H: 0.17%
C: -0.3%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.58%
H: 1.01%
C: -0.58%
keytruda bladder cancer treatment application advanced
Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1
Published: 2023-12-07 (Crawled : 17:00) - biospace.com/
DARE | $0.299 5.77% 5.45% 970K
|
Health Technology
|
| O: 6.54%
H: 0.0%
C: -13.54%
fda drug bioscience clearance application
Checkmarx is a 2023 Gartner® Peer Insights™ Customers' Choice for Application Security Testing for Fifth Consecutive Year
Published: 2023-12-04 (Crawled : 17:00) - prnewswire.com
IT | $449.61 0.07% 0.0% 390K
|
Commercial Services
|
| O: -0.98%
H: 1.09%
C: 0.63%
gartner year security choice application
AnHeart Therapeutics and Innovent Announce China’s NMPA Has Accepted a New Drug Application for Taletrectinib (ROS1 Inhibitor)
Published: 2023-11-22 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.74%
H: 0.71%
C: 0.71%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.56%
H: 1.06%
C: -0.24%
drug application therapeutics
Snowday Announcements for Application Development: Snowpark Container Services, Snowflake Native Apps, Hybrid Tables and more!
Published: 2023-11-01 (Crawled : 17:00) - snowflake.net
SNOW | $148.41 -0.26% -0.04% 3.8M
|
Technology Services
|
| O: 0.12%
H: 0.29%
C: -0.72%
application
Teck Provides Update on QBME Regulatory Application
Published: 2023-10-24 (Crawled : 17:00) - globenewswire.com
TECK | $47.72 1.1% 0.0% 3.1M
|
Non-Energy Minerals
|
| O: -4.43%
H: 0.89%
C: -4.95%
update application
VHC Health Extends Multi-Year Renewal of Digital Front Door Application with Phunware
Published: 2023-10-17 (Crawled : 17:00) - phunware.com
PHUN | $6.84 14.0% 12.28% 880K
|
Technology Services
|
| O: -1.7%
H: 8.88%
C: 4.02%
multi-year health application
How a Leading Bank Reduced Credit Application Fraud with Biometrics
Published: 2023-10-12 (Crawled : 17:00) - aware.com
AWRE | $1.69 0.6% 0.59% 22K
|
Communications
|
| O: -1.43%
H: 0.72%
C: 0.0%
application
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published: 2023-09-25 (Crawled : 17:00) - biospace.com/
RNAZ | $0.5195 3.59% 3.46% 270K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive cancer application therapeutics results glioblastoma
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12Announces Plans to File IND Application in Neuropathic Pain
Published: 2023-09-07 (Crawled : 17:00) - biospace.com/
ARTL | $1.29 -1.9% -1.94% 14K
|
Health Technology
|
| O: 3.83%
H: 22.13%
C: -25.45%
art26 fda positive meeting application
Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
Published: 2023-08-14 (Crawled : 17:00) - biospace.com/
QRON | $0.213 0% 3.2K
|
Manufacturing
| Email alert
Add to watchlist
patent disease application
FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA)
Published: 2023-08-14 (Crawled : 17:00) - biospace.com/
MYMD | $2.5 11.11% 10.0% 54K
|
Manufacturing
|
| O: -7.64%
H: 2.97%
C: 0.0%
fda drug application study
Bionic Announces Integration with ServiceNow for Industry Leading Application Security Posture Management
Published: 2023-08-09 (Crawled : 17:00) - prnewswire.com
NOW | $731.36 -0.69% 0.0% 790K
|
Technology Services
|
| O: -0.24%
H: 0.63%
C: -0.22%
management integration security servicenow application
Datadog Announces Bits, an AI Assistant to Help Engineers Quickly Resolve Application Issues
Published: 2023-08-03 (Crawled : 17:00) - prnewswire.com
DDOG | News | $125.0 1.17% 1.16% 2.6M
|
Technology Services
|
| O: -0.57%
H: 1.27%
C: 0.83%
resolve application
Datadog Introduces Intelligent Test Runner to Help Developers Reduce the Time to Deploy Application Changes
Published: 2023-08-03 (Crawled : 17:00) - prnewswire.com
DDOG | News | $125.0 1.17% 1.16% 2.6M
|
Technology Services
|
| O: -0.57%
H: 1.27%
C: 0.83%
test application
Powerfleet Unveils Sustainability Data-Powered Application
Published: 2023-06-28 (Crawled : 17:00) - globenewswire.com
PWFL | $4.06 0.25% 0.25% 800K
|
Electronic Technology
|
| O: -0.71%
H: 2.14%
C: 0.89%
application
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
Published: 2023-03-31 (Crawled : 17:00) - biospace.com/
CABA | $13.96 -7.86% -8.52% 1.1M
|
Health Technology
|
| O: 7.75%
H: 11.76%
C: 8.1%
caba-201 fda lupus treatment clearance application
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.